Citadel Advisors »

Drugs Made In America Acquisitn Unt shares owned by Citadel Advisors

Quarter-by-quarter ownership of Drugs Made In America Acquisitn Unt (DMAAU) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Drugs Made In America Acquisitn Unt

Tip: Access up to 7 years of quarterly data

All positions including Drugs Made In America Acquisitn Unt held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Drugs Made In America Acquisitn Unt by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $125k 12k 10.45
2025-06-30 $145k 14k 10.32
2025-03-31 $159k 16k 10.12

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Drugs Made In America Acquisitn Unt

Omni Event Management
Wolverine Asset Management
Rivernorth Capital Management
DLD Asset Management
Clear Street
Robinson Capital Management
Tuttle Tactical Management
UBS Group
Citadel Advisors

View all funds holding Drugs Made In America Acquisitn Unt